Sex differences in chemotherapy completion, toxicities, and survival in colon cancer: an analysis of 2201 patients from CALGB/SWOG 80702 (alliance).
      Google Scholar   
Citation:
J Natl Cancer Inst
Year:
2025
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
epub
Note:
Methodological:
No
Biospecimen:
Yes
SDC:
No
Book Volume:
15
Parents:
4566  
Children:
None
Program:
OGC
Primary Committee:
GI
Sec. Committees:
   
Pharmas:
Pfizer  
Grants:
U10CA180821, U10CA180882, U24CA196171; UG1CA189830, UG1CA189859, UG1CA233180, UG1CA233290, UG1CA233339;U10CA180863, CCS707213 (CCTG); UG1CA233196, U10CA180820 (ECOG); U10CA180868 (NRG Oncology); U10CA180888, UG1CA233163 (SWOG)  
Corr. Author:
 
Authors:
                                   
Networks:
COLUMBUS, HEARTLAND, LAPS-IL057, LAPS-MA036, LAPS-MO011, LAPS-NY016, MONTEFIORE, OH027   
Study
CALGB-80702
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords: